A diversity of Antibiotic-resistant Staphylococcus spp. in a Public Transportation System

Osong Public Health and Research Perspectives

Volumn 2, Issue 3, 2011, Pages 202-209

  Yeh, Pamela J ^a,b   Simon, Dawn M ^c   Millar, Jess A ^a   Alexander, H Forrest ^a   Franklin, Darleen ^d  

^a PORTLAND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NEBRASKA AT KEARNEY   (United States)

^d SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

Antibiotic resistance; Community acquired infections; Environmental microbiology; Methicillin resistant Staphylococcus aureus; Pathogen transmission; Staphylococcus; Transportation

Indexed keywords

AMPICILLIN; BACITRACIN; COTRIMOXAZOLE; PENICILLIN G; RNA 16S; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIUM COLONY; BACTERIUM CONTAMINATION; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISK DIFFUSION; MICROBIAL DIVERSITY; MOTOR VEHICLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; RAILWAY; RNA SEQUENCE; STAPHYLOCOCCUS; TRAFFIC AND TRANSPORT; UNITED STATES; URBAN AREA;

EID: 84855199998     PISSN: 22109099     EISSN: 22109110     Source Type: Journal    
DOI: 10.1016/j.phrp.2011.11.047     Document Type: Article

References (69)

1. Ehrenkranz N.J. Person-to-person transmission of Staphylococcus aureus. Quantitative characterization of nasal carriers spreading infection. N Engl J Med 1964 Jul 30, 271:225-230.
2. Scott E., Bloomfield S.F. The survival and transfer of microbial contamination via cloths, hands and utensils. J Appl Bacteriol 1990 Mar, 68(3):271-278.
3. Brook J., Brook I. Recovery of organisms from the handrails of escalators in the public metro rail system in Washington, D.C. J Environ Health 1994 Nov, 57(4):13-14.
4. Rusin P., Maxwell S., Gerba C. Comparative surface-to-hand and fingertip-to-mouth transfer efficiency of gram-positive bacteria, gram-negative bacteria, and phage. J Appl Microbiol 2002, 93(4):585-592.
5. Kassem I.I., Sigler V., Esseili M.A. Public computer surfaces are reservoirs for methicillin-resistant staphylococci. ISME J 2007 Jul, 1(3):265-268.
6. Stepanovic S., Cirkovic I., Djukic S., et al. Public transport as a reservoir of methicillin-resistant staphylococci. Lett Appl Microbiol 2008 Oct, 47(4):339-341.
7. Carleton H.A., Diep B.A., Charlebois E.D., et al. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 2004 Nov 15, 190(10):1730-1738.
8. Zetola N., Francis J.S., Nuermberger E.L., Bishai W.R. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005 May, 5(5):275-286.
9. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006 Aug 17, 355(7):666-674.
10. Deurenberg R.H., Stobberingh E.E. The evolution of Staphylococcus aureus. Infect Genet Evol 2008 Dec, 8(6):747-763.
11. Reynolds K.A., Watt P.M., Boone S.A., Gerba C.P. Occurrence of bacteria and biochemical markers on public surfaces. Int J Environ Health Res 2005 Jun, 15(3):225-234.
12. Tunc K., Olgun U. Microbiology of public telephones. J Infect 2006 Aug, 53(2):140-143.
13. Otter J.A., French G.L. Bacterial contamination on touch surfaces in the public transport system and in public areas of a hospital in London. Lett Appl Microbiol 2009 Dec, 49(6):803-805.
14. Levine M. Downtown redevelopment as an urban growth strategy: a critical appraisal of the Baltimore renaissance. J Urban Aff 1987 Jun, 9(2):103-123.
15. Gotham K. A city without slums: urban renewal, public housing, and downtown revitalization in Kansas City, Missouri. Am J Econ Sociol 2001 Jan, 60(1):285-316.
16. Transportation control strategies for the state implementation plan: city of Philadelphia 1973, Environmental Protection Agency, Environmental Protection Agency, EPA, Research Triangle Park, NC, Contract No. APTD-1370 US.
17. Thompson L. High-speed rail (HSR) in the United States-why isn't there more?. Jpn Railw Transp Rev 1994 Oct, 3:32-39.
18. Bose R., Srinivasachary V. Policies to reduce energy use and environmental emissions in the transport sector: a case of Delhi city. Energ Policy 1997 Dec, 25(14-15):1137-1150.
19. Barrero R. Energy savings in public transport. IEEE Veh Tech 2008 Sep, 3(3):26-36.
20. Simoes R.R., Aires-de-Sousa M., Conceicao T., et al. High prevalence of EMRSA-15 in Portuguese public buses: a worrisome finding. PLoS One 2011, 6(3):e17630.
21. United States Census Bureau Annual estimates of the population of metropolitan and micropolitan statistical areas: April 1, 2000 to July 1, 2008 [Internet] 2009, U.S. Census Bureau, Available from:, [updated Mar 19; cited 2011 Aug 8]. http://www.census.gov/compendia/smadb/TableC-02.xls.
22. United States Census Bureau 2009 American Community Survey: Portland city, Oregon S0801. Commuting characteristics by sex [Internet] 2009, U.S. Census Bureau, Available from:, [cited 2011 Aug 5]. http://factfinder.census.gov/servlet/STTable?_bm=y&-context=st&-qr_name=ACS_2009_5YR_G00_S0801&-ds_name=ACS_2009_5YR_G00_&-tree_id=5309&-redoLog=true&-_caller=geoselect&-geo_id=16000US4159000&-format=&-_lang=en.
23. American Public Transport Association Transit ridership report: first quarter 2011, American Public Transport Association, Washington, DC.
24. Lewis R. The rise of antibiotic-resistant infections. FDA Consum 1995 Sep, 29(7):11-15.
25. Normark B.H., Novak R., Ortqvist A., et al. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin Infect Dis 2001 Feb 15, 32(4):552-558.
26. Popovich K.J., Weinstein R.A., Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?. Clin Infect Dis 2008 Mar 15, 46(6):787-794.
27. Adcock P.M., Pastor P., Medley F., et al. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 1998 Aug, 178(2):577-580.
28. Shahin R., Johnson I.L., Jamieson F., et al. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Arch Pediatr Adolesc Med 1999 Aug, 153(8):864-868. Toronto Child Care Center Study Group.
29. Aires de Sousa M., Conceicao T., Simas C., de Lencastre H. Comparison of genetic backgrounds of methicillin-resistant and -susceptible Staphylococcus aureus isolates from Portuguese hospitals and the community. J Clin Microbiol 2005 Oct, 43(10):5150-5157.
30. Roberts M.C., Soge O.O., No D., et al. Isolation and characterization of methicillin-resistant Staphylococcus aureus from fire stations in two northwest fire districts. Am J Infect Control 2011 Jun, 39(5):382-389.
31. Roberts M.C., Soge O.O., No D., et al. Characterization of methicillin-resistant Staphylococcus aureus isolated from public surfaces on a university campus, student homes and local community. J Appl Microbiol 2011 Jun, 110(6):1531-1537.
32. Hill L.R. The Adansonian classification of the staphylococci. J Gen Microbiol 1959 Apr, 20(2):277-283.
33. Chapman G.H. The significance of sodium chloride in studies of staphylococci. J Bacteriol 1945 Aug, 50:201-203.
34. Evans J.B. Anaerobic fermentation of mannitol by staphylococci. J Bacteriol 1947 Aug, 54(2):266.
35. Edmiston C.E., Schmitt D.D., Seabrook G.R. Coagulase-negative staphylococcal infections in vascular surgery: epidemiology and pathogenesis. Infect Control Hosp Epidemiol 1989 Mar, 10(3):111-117.
36. Moreillon P., Entenza J.M., Francioli P., et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 1995 Dec, 63(12):4738-4743.
37. von Eiff C., Peters G., Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002 Nov, 2(11):677-685.
38. Longauerova A. Coagulase negative staphylococci and their participation in pathogenesis of human infections. Bratisl Lek Listy 2006, 107(11-12):448-452.
39. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing 2007, CLSI approved standard M100-S17, CLSI, Wayne, PA.
40. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004, 32(5):1792-1797.
41. Talavera G., Castresana J. Improvement of phylogenies after removing divergent and ambiguously aligned blocks from protein sequence alignments. Syst Biol 2007 Aug, 56(4):564-577.
42. Stamatakis A., Hoover P., Rougemont J. A rapid bootstrap algorithm for the RAxML Web servers. Syst Biol 2008 Oct, 57(5):758-771.
43. Wilkoff L.J., Westbrook L., Dixon G.J. Factors affecting the persistence of Staphylococcus aureus on fabrics. Appl Microbiol 1969 Feb, 17(2):268-274.
44. Andersen B.M., Rasch M., Kvist J., et al. Floor cleaning: effect on bacteria and organic materials in hospital rooms. J Hosp Infect 2009 Jan, 71(1):57-65.
45. Berry M.A. Healthy school environment and enhanced educational performance 2002, Carpet and Rug Institute, Washington, D.C.
46. Dharan S., Mourouga P., Copin P., et al. Routine disinfection of patients' environmental surfaces. Myth or reality?. J Hosp Infect 1999 Jun, 42(2):113-117.
47. Suzuki A., Namba Y., Matsuura M., Horisawa A. Bacterial contamination of floors and other surfaces in operating rooms: a five-year survey. J Hyg (Lond) 1984 Dec, 93(3):559-566.
48. Evans J.B. Studies of staphylococci with special reference to the coagulase-positive types. J Bacteriol 1948 Jun, 55(6):793-800.
49. Finegold S.M., Sweeney E.E. New selective and differential medium for coagulase-positive staphlococci allowing rapid growth and strain differentiation. J Bacteriol 1961 Apr, 81:636-641.
50. Bruins M.J., Juffer P., Wolfhagen M.J., Ruijs G.J. Salt tolerance of methicillin-resistant and methicillin-susceptible Staphylococcus aureus. J Clin Microbiol 2007 Feb, 45(2):682-683.
51. Kassem I.I. Concerning public transport as a reservoir of methicillin-resistant staphylococci. Lett Appl Microbiol 2009 Feb, 48(2):268.
52. Mastroianni A., Coronado O., Nanetti A., et al. Community-acquired pneumonia due to Staphylococcus cohnii in an HIV-infected patient: case report and review. Eur J Clin Microbiol Infect Dis 1995 Oct, 14(10):904-908.
53. Fernandes A.P., Perl T.M., Herwaldt L.A. Staphylococcus cohnii: a case report on an unusual pathogen. Clin Perform Qual Health Care 1996 Apr-Jun, 4(2):107-109.
54. Basaglia G., Moras L., Bearz A., et al. Staphylococcus cohnii septicaemia in a patient with colon cancer. J Med Microbiol 2003 Jan, 52(Pt 1):101-102.
55. Pinna A., Zanetti S., Sotgiu M., et al. Identification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infections. Br J Ophthalmol 1999 Jul, 83(7):771-773.
56. Szewczyk E.M., Rozalska M., Cieslikowski T., Nowak T. Plasmids of Staphylococcus cohnii isolated from the intensive-care unit. Folia Microbiol (Praha) 2004, 49(2):123-131.
57. Vinh D., Nichol K., Rand F., Karlowsky J. Not so pretty in pink: Staphylococcus cohnii masquerading as methicillin-resistant Staphylococcus aureus on chromogenic media. J Clin Microbiol 2006 Dec, 44(12):4623-4624.
58. Hovelius B., Mardh P.A. Staphylococcus saprophyticus as a common cause of urinary tract infections. Rev Infect Dis 1984 May-Jun, 6(3):328-337.
59. Siqueira J.F., Lima K.C. Staphylococcus epidermidis and Staphylococcus xylosus in a secondary root canal infection with persistent symptoms: a case report. Aust Endod J 2002 Aug, 28(2):61-63.
60. Kuroda M., Yamashita A., Hirakawa H., et al. Whole genome sequence of Staphylococcus saprophyticus reveals the pathogenesis of uncomplicated urinary tract infection. Proc Natl Acad Sci U S A 2005 Sep 13, 102(37):13272-13277.
61. Dordet-Frisoni E., Dorchies G., De Araujo C., et al. Genomic diversity in Staphylococcus xylosus. Appl Environ Microbiol 2007 Nov, 73(22):7199-7209.
62. Vuong C., Otto M. Staphylococcus epidermidis infections. Microbes Infect 2002 Apr, 4(4):481-489.
63. Froggatt J.W., Johnston J.L., Galetto D.W., Archer G.L. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents Chemother 1989 Apr, 33(4):460-466.
64. Bartoszewicz M., Nowicka J., Przondo-Mordarska A. Selected features determine pathogenicity of Staphylococcus haemolyticus. Med Dosw Mikrobiol 2003, 55(3):225-229.
65. Takeuchi F., Watanabe S., Baba T., et al. Whole-genome sequencing of Staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of human-colonizing staphylococcal species. J Bacteriol 2005 Nov, 187(21):7292-7308.
66. Bera A., Gotz F., Biswas R., Herbert S. The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect Immun 2006 Aug, 74(8):4598-4604.
67. Kamath U., Singer C., Isenberg H.D. Clinical significance of Staphylococcus warneri bacteremia. J Clin Microbiol 1992 Feb, 30(2):261-264.
68. Arslan F., Saltoglu N., Mete B., Mert A. Recurrent Staphylococcus warnerii prosthetic valve endocarditis: a case report and review. Ann Clin Microbiol Antimicrob 2011, 10:14.
69. Center K.J., Reboli A.C., Hubler R., et al. Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri. J Clin Microbiol 2003 Oct, 41(10):4660-4665.